Cognition Therapeutics (CGTX) Change in Receivables (2020 - 2022)
Cognition Therapeutics (CGTX) reported Change in Receivables of -$2000.0 for Q4 2022, down 101.4% year-over-year from $143000.0 in Q4 2021, and down 200.0% on a QoQ basis from $2000.0 in Q3 2022.
Cognition Therapeutics (CGTX) has 3 years of Change in Receivables data on file, last reported at -$2000.0 in Q4 2022.
- Quarterly Change in Receivables fell 101.4% year-over-year to -$2000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$467000.0 (down 285.95% YoY) and the FY2022 annual result came in at -$467000.0, down 285.95% from the prior year.
- Change in Receivables retreated to -$2000.0 in Q4 2022 per CGTX's latest filing, from $2000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $143000.0 in Q4 2021 and bottomed at -$467000.0 in Q1 2022.
- The 3-year median for Change in Receivables is $13500.0 (2021), against an average of -$65750.0.
- The widest annual swing landed in 2021, when Change in Receivables surged 130.65%; it then tumbled 841.27% in 2022.
- Tracing CGTX's Change in Receivables over 3 years: stood at $62000.0 in 2020, then jumped by 130.65% to $143000.0 in 2021, then slumped by 101.4% to -$2000.0 in 2022.
- Per Business Quant, the three latest CGTX Change in Receivables figures stand at -$2000.0 (Q4 2022), $2000.0 (Q3 2022), and -$467000.0 (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -1.20 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Mar 31, 2022 | -467,000.00 |
| Mar 31, 2022 | -467,000.00 |
| Dec 31, 2021 | 143,000.00 |
| Dec 31, 2021 | 143,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | -352,000.00 |
| Jun 30, 2021 | -352,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Dec 31, 2020 | 62,000.00 |
| Dec 31, 2020 | 62,000.00 |